No abstract available.
Glaucoma*

No abstract available.
Glaucoma* ; Stents*

We observed the change of intraocular pressure(IOP)and the complications after contact transscleral cyclophotocoagulation with Neodymium:YAG (Nd:YAG)laser for the refractory glaucoma patients. Refractory glaucoma in twenty eyes was treated with contact transscleral continuous-wave Nd:YAG laser cyclophotocoagulation with a sapphire-tipped probe. Using 7W of power for 0.7 seconds with 32 applications and intraocular pressure(IOP) was measured at 1 day, 1 week, 1 month, 2 months, 3 months, 4 months, 5 months and 6 months, postoperatively. The intraocular pressure(IOP)decreasing rate was 62% and the success rate was 60%at 6 months postoperatively. It is suggested that contact transscleral cyclophotocoagulation with Nd:YAG laser is useful in lowering IOP in refractory glaucoma patients.
Glaucoma* ; Humans

Iridoschisis is a very rare condition occurining in either sex, usually bilaterally. Glaucoma occurs in approximately 50% of the cases, and other ocular defects may be present in iridoschisis. It is considered as a degenerative process related to senescene. We experienced two cases of typical iridoschisis and report the cases with a review of the literature because iridoschisis is not reported yet in our country.
Aging ; Glaucoma

No abstract available.
Glaucoma, Neovascular*

The authors experienced a case of secondary glaucoma combined with mesodermal dysgenesis of anterior segment, which disclosed extensive peripheral iridocorneal adhesion of congenital origin while his fellow eye revealed a sclerocornea. This case is extremely rare and entirely different from the previously reported Axenfeld's and Rieger's anomalies. We report this interesting case with brief review of the literatures.
Glaucoma* ; Mesoderm*

To analyze the results of intraocular pressure reduction by diode laser contact transscleral cyclophotocoagulation (TSCPC) in eyes with neovascular glaucoma, six eligible eyes (6 patients) diagnosed with neovascular glaucoma, were treated with the IRIS Medical Oculight SLx diode laser (810 nm) system.19-20 laser applications at 1.25 to 2.0 W and 2.0 second duration were done with the G-Probe fiberoptic delivery system.Mean pre-treatment IOP was 41+_ 8.334 mm Hg (range 30 to 55 mm Hg).All eyes were painful.Vision ranged from 2o/200 to LP.After average follow up of 7 months (13 to 1 month), mean IOP reduction was 23.33 +_ 8.358 mm Hg (range 18 to 40 mm Hg)Vision did not worsen in all eyes,Two eyes depost-operative hyphema, which cleared spontaneously within days.None developed phthisis bulbi.Contact diode laser transscleral cyclophotocoagulation reduces pain and intraocular pressure in eyes with neovascular glaucoma.
Human ; GLAUCOMA

OBJECTIVE:To determine surgical outcome of patients who underwent trabeculectomy in our institution METHODOLOGY:The medical records of glaucoma patient who underwent primary trabeculectomy from 1998 - 2000 in our institution are reviewed.All types of glaucoma are included except congenital and developmental glaucoma.Surgical outcome is assessed in terms of final intraocular pressure (IOP).Outcome is defined as a success when the post-operative IOP is 21 mm Hg or lower.The operation is a failure if IOP is greater than 21 mm Hg despite medication and suture lysis.Data are analyzed using the Chi-Square test. RESULTS: 56 eyes of 45 patients are included in the study.Mean age is 59 - 70 years with s standard deviation (SD) of +_9.50.Mean follow-up is 8 months (SD +_7.97).Of the the 56 eyes, success is obtained in 43 eyes (76%), qualified success is achieved in 8 eyes (14.3%) and failure is seen in 5 eyes (8.9% which is evident on the 14th month +_ 11.39 months.There is a significant number of unsuccessful cases when compared to failed cases (p<(p<0.05 ) respectively.However, no sigificant difference existed between qualified success and failed cases (p<0,05).Increase in pressure is observed between 5 and 10 months after trabeculectomy.Mean pressure is highest during the 5th month. CONCLUSION:There is a high success rate of patients who underwentrabeculectomy in our institution
Human ; GLAUCOMA ;

PURPOSE:To determine the outcomes of acute angle closure glaucoma management. METHODOLOGY:Case-control study using computer-aided imaging as a screening test in a given population. RESULTS:There is a wide variability in cup and disc areas among g normals CONCLUSION:C:D alone has a poor predictive value for diagnosing glaucoma.Optic disc size with C:D is just as sensitive and specific in screening for glaucoma.Cup and disc areas are positively correlated for normal and glaucoma suspects.
Human ; GLAUCOMA ;

Objective: To identify the risk factors for conjunctival tube erosion (CTE) in eyes implanted with Ahmed® glaucoma valve (AGV) device Method: This is a retrospective study conducted at a private eye institution. Medical records of patients who underwent AGV implantation surgery from January 2004 to December 2013 were reviewed. Eyes with at least 24 months of follow-up and complete records were included. Several variables from the pre-, intra-, and postoperative periods were collected. The primary outcome was development of CTE after AGV surgery. Univariable logistic regression and multivariable analysis were employed. Results: Forty-six (46) eyes of 45 patients were included in the study. The mean follow-up was 50.2 months (range: 24-140 months). Eight (8) eyes developed CTE (17.4%). Univariable logistic regression analysis identified female gender (P =0.064), presence of diabetes (P =0.083), prior intraocular surgeries (P =0.09), and postoperative use of antiglaucoma medications (P =0.086) to be marginally significant risk factors for CTE. On multivariable analysis, only female gender (OR=15.4, P =0.033) and diabetes (OR=14.1, P =0.031) were found to be significantly associated with CTE. Conclusion Risk factors for CTE following AGV implantation include female gender and presence of diabetes.
Human ; Glaucoma